NCT06899867 Comparing Montiroing Cardiac Index by Transpulmonary Thermodilution and Transesophageal Echocardiography During Liver Transplantation
| NCT ID | NCT06899867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Liver Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-11-27 |
| Primary Completion | 2024-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-11-27 with a primary completion date of 2024-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Liver transplantation poses challenges due to hemodynamic changes throughout different surgical phases. Monitoring devices are essential for therapeutic adjustments. Transpulmonary thermodilution and transesophageal echocardiography are commonly used, but thermodilution may have limitations depending on the surgery. This study aims to compare cardiac index variations between thermodilution and transesophageal echocardiography during liver transplantation. Patients undergo monitoring with both techniques. Measurements are recorded and reported at multiple time points.
Eligibility Criteria
Inclusion Criteria: * liver transplantation * adults Exclusion Criteria: * \- Oesophageal varice ligation \< 14 days * Mediastinal radiotherapy * Femoral bypass * Severe lower extremity artery disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06899867 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06899867 currently recruiting?
Yes, NCT06899867 is actively recruiting participants. Contact the research team at alice.blet@chu-lyon.fr for enrollment information.
Where is the NCT06899867 trial being conducted?
This trial is being conducted at France, France.
Who is sponsoring the NCT06899867 clinical trial?
NCT06899867 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 30 participants.